The Valley Desk

NCT06161974 · Interventional trial

Study of Olutasidenib and Temozolomide in HGG

Overall registry status Recruiting

Phase 2

Conditions Astrocytoma, Astrocytoma, Grade III, Astrocytoma, Grade IV, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, High Grade Glioma, IDH1 Mutation, IDH1 R132, IDH1 R132C, IDH1 R132G, IDH1 R132H, IDH1 R132L, IDH1 R132S, Metastatic Brain Tumor, Oligodendroglioma, Spinal Tumor, Thalamus Tumor, WHO Grade III Glioma, WHO Grade IV Glioma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov